Cyclerion Therapeutics, Inc.

CYCN · Nasdaq · SIC 2834: Pharmaceutical Preparations
115
SEC Filings

Business Summary

, Part I, Item 1A. Risk Factors, and Part II, Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations, but are also contained elsewhere in this Annual Report. In some cases, you can identify forward-looking statements by the words may, might, will, would, could, should, believes, estimates, projects, potential, expects, plans, seeks, intends, evaluates, pursues, anticipates, continues, designs, impacts, affects, forecasts, target, outlook, initiative, objecti...

Next Earnings

Q2 FY2026 — expected 2026-09-14

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCYCNdiscussed_in_filing Cybersecurity
topic_mentionCYCNdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001193125-26-132193EDGAR60K words
2025-03-042024-12-310000950170-25-032037EDGAR—
2024-03-052023-12-310000950170-24-025935EDGAR—
2023-03-222022-12-310000950170-23-009223EDGAR—
2022-02-242021-12-310000950170-22-001958EDGAR—
2021-02-252020-12-310001564590-21-008434EDGAR—
2020-03-122019-12-310001104659-20-032554EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001193125-25-277749EDGAR19K words
2025-08-052025-06-300000950170-25-103123EDGAR—
2025-05-062025-03-310000950170-25-064493EDGAR—
2024-11-142024-09-300000950170-24-127116EDGAR—
2024-08-072024-06-300000950170-24-092257EDGAR—
2024-05-072024-03-310000950170-24-054602EDGAR—
2023-11-132023-09-300000950170-23-063023EDGAR—
2023-07-282023-06-300000950170-23-035558EDGAR—
2023-05-122023-03-310000950170-23-021448EDGAR—
2022-11-032022-09-300000950170-22-021966EDGAR—
2022-08-092022-06-300000950170-22-016032EDGAR—
2022-05-042022-03-310000950170-22-007378EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-010001193125-26-137909EDGAR62K words
2026-02-170001193125-26-053035EDGAR—
2026-01-060001193125-26-003509EDGAR—
2025-12-010001193125-25-304067EDGAR—
2025-09-230001193125-25-213332EDGAR—
2025-06-180001193125-25-142765EDGAR—
2025-05-070001193125-25-115089EDGAR—
2025-03-250001193125-25-062612EDGAR—
2024-12-170001193125-24-280125EDGAR—
2024-08-070001193125-24-195410EDGAR—

115 total filings indexed. 86 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001755237
TickerCYCN
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedMA

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: a4bb1625dd97a6cfd0b81695210128b4b82c622efba5c0448cbfaf6865c3a86c
parent: f524567f9cd7058450f88c41a01159d787ac2afda692c3bd2b37a2f3eb66df0e
content hash: 4420df954982fd466887f0d39a5eabfa594cad8288eb7bfc80265d5e1b89c8c9
signed: 2026-04-13T04:44:35.647Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf